Stock Code: 000919 stock abbreviation: Jinling Pharmaceutical Company Limited(000919) Announcement No.: 2022-014
Jinling Pharmaceutical Company Limited(000919)
Insider information about the company’s restricted stock incentive plan in 2021
And the self inspection report on the purchase and sale of the company’s shares by the incentive object
The company and all members of the board of directors guarantee that the information disclosed is true, accurate and complete without false records, misleading statements or major omissions.
December 29, 2021, Jinling Pharmaceutical Company Limited(000919) (hereinafter referred to as the “company”)
The 15th meeting of the 8th board of directors was held to consider and adopt the Jinling Pharmaceutical Company Limited(000919) 2021 restricted stock incentive plan (Draft) and its summary and other relevant proposals, with specific details
For details, please refer to China Securities Journal, securities times and the China Securities Journal on December 31, 2021
Relevant announcements disclosed by Shanghai Securities News and cninfo.
According to the requirements of laws, regulations and normative documents such as the measures for the administration of equity incentives of listed companies, the measures for the administration of information disclosure of listed companies, the stock listing rules of Shenzhen Stock Exchange, the self regulatory guide for listed companies of Shenzhen Stock Exchange No. 1 – business handling, etc, The company has taken sufficient and necessary confidentiality measures for the 2021 restricted stock incentive plan (hereinafter referred to as the “incentive plan”) and registered the insiders of the incentive plan. According to relevant requirements, the company shall provide insider information and incentive objects of this incentive plan six months before the first public disclosure of this incentive plan
(from June 30, 2021 to December 30, 2021, hereinafter referred to as “self inspection period”)
Conduct self inspection on the trading of the company’s shares. The details are as follows:
1、 Scope and procedure of verification
(I) the verification object is the insider of the incentive plan and the incentive object. The company and all members of the board of directors guarantee that the information disclosed is true, accurate and complete without false records, misleading statements or major omissions.
(II) the insiders of this incentive plan have filled in the registration form of insiders.
(III) the company inquired the Shenzhen Branch of China Securities Depository and Clearing Co., Ltd. about the purchase and sale of the company’s shares by the verification object during the self inspection period, and Shenzhen Branch of China Securities Depository and Clearing Co., Ltd. issued the inquiry certificate of shareholding and share change of information disclosure obligor and the detailed list of shareholder share change.
2、 Check the sale of the object
(I) purchase and sale of shares by incentive objects and other subjects
According to China Securities Depository and Clearing Co., Ltd. Shenzhen Branch, January 7, 2021
According to the inquiry certificate on Shareholding and share change of information disclosure obligors and the detailed list of shareholder share change issued on September, during the self-examination, the following incentive objects had the behavior of buying and selling the company’s shares, and the relevant information is as follows:
Serial number name job title total purchase (shares) total sale (shares) during trading period
1 yuan Yongjian middle-level managers and 900 core backbone personnel from July 28, 2021 to November 22, 2021
2. Lu Jian’s middle-level managers and core backbone personnel from September 9, 2021 to 95700 82000 on December 27, 2021
3 Gu Lin middle managers, 7500 core backbone personnel from July 27 to 6500, 2021 / 12 / 28
4 Li Yingjun, middle-level manager, 2021 / 7 / 1 to – 4000 core backbone personnel, 2021 / 8 / 6
5 chendi middle management, 2021 / 7 / 2 to 8000 – core backbone personnel 2021 / 11 / 15
According to the verification of the company, the purchase and sale of the company’s shares by the above incentive objects of the company during the self inspection period is a normal securities investment based on the information publicly disclosed by the company and its independent judgment on the trading situation of the secondary market; When buying and selling the company’s shares during the above-mentioned period, he did not get the inside information of the company’s planning of the incentive plan, nor did any insider disclose the inside information of the incentive plan to him, and there was no trading with the inside information.
(II) trading of stocks by other insiders
According to the inquiry certificate on Shareholding and share change of information disclosure obligors and the detailed list of shareholder share change issued by Shenzhen Branch of China Securities Depository and Clearing Corporation Limited on January 7, 2022, other insiders of the incentive plan did not buy or sell the company’s shares during the self inspection period.
3、 Conclusion of this verification
In the process of planning this incentive plan, the company limited the scope of personnel involved in the planning and discussion in strict accordance with the measures for the administration of equity incentive of listed companies, the management system of insider information and insiders and the relevant internal confidentiality system of the company, timely registered the relevant company personnel and intermediaries exposed to insider information, and took corresponding confidentiality measures. Before the company publicly disclosed the announcement related to the incentive plan for the first time, no information disclosure was found.
To sum up, it is verified that within 6 months before the first public disclosure of the incentive plan, no verification object has used the insider information of the incentive plan for stock trading.
4、 Documents for future reference
1. Inquiry certificate of shareholding and share change of information disclosure obligor issued by China Securities Depository and Clearing Co., Ltd. Shenzhen Branch;
2. Detailed list of changes in shareholders’ shares issued by Shenzhen Branch of China Securities Depository and Clearing Corporation.
It is hereby announced.
Jinling Pharmaceutical Company Limited(000919) board of directors January 27, 2002
